Axsome Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 6,149 | 0.0% | 33,667 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 4,168 | 0.0% | 34,315 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 3,582 | 0.0% | 34,313 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 3,406 | 0.0% | 29,205 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 2,504 | 0.0% | 29,594 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 2,661 | 0.0% | 29,608 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 2,459 | 0.0% | 30,551 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 2,494 | 0.0% | 31,251 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 2,642 | 0.0% | 33,192 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 2,557 | 0.0% | 36,588 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 2,988 | 0.0% | 41,577 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 2,500 | 0.0% | 40,535 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 3,015 | 0.0% | 39,096 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,645 | 0.0% | 36,858 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 1,394 | 0.0% | 36,391 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1,361 | 0.0% | 32,892 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 1,352 | 0.0% | 35,788 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1,153 | 0.0% | 34,979 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,584 | 0.0% | 38,306 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 2,365 | 0.0% | 41,778 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 3,415 | 0.0% | 41,917 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 2,990 | 0.0% | 41,962 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 3,437 | 0.0% | 41,773 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 2,414 | 0.0% | 41,041 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 3,973 | 0.0% | 38,437 | 12/31/2019 |